Complex therapy of atopic keratoconjunctivitis in children
- Authors: Yani E.V1, Pozdnyakova V.V1, Yakushina L.N1, Grishakova M.B1
-
Affiliations:
- The Helmholtz Moscow Research Institute of Eye Diseases
- Issue: Vol 9, No 2 (2014)
- Pages: 36-38
- Section: Articles
- URL: https://journals.rcsi.science/1993-1859/article/view/37580
- DOI: https://doi.org/10.17816/rpoj37580
- ID: 37580
Cite item
Full Text
Abstract
The purpose of the study was to evaluate the efficacy and acceptability of the drug Restasis® in treatment of atopic keratoconjunctivitis in children. The study enrolled 16 patients (32 eyes) with atopic keratoconjunctivitis at the age from 10 to 16 years. Restasis® put on 2 drops 2 times a day during 6 months. It was determined that Restasis® is well tolerated by patients, gives significant and stable therapeutic effect confirmed by long period of clinical observation. Besides, it improves dry eye symptoms, reduces the risk of complications in long-term use of corticosteroids.
Full Text
##article.viewOnOriginalSite##About the authors
E. V Yani
The Helmholtz Moscow Research Institute of Eye Diseases
Email: yandoc@yandex.ru
V. V Pozdnyakova
The Helmholtz Moscow Research Institute of Eye Diseases
L. N Yakushina
The Helmholtz Moscow Research Institute of Eye Diseases
M. B Grishakova
The Helmholtz Moscow Research Institute of Eye Diseases
References
- Курбачева O.M. Поллинозы. Современные аспекты диагностики и лечения аллергических заболеваний. М.; 2009.
- Смирнова Г.И. Современные топические кортикостероиды в лечении аллергодерматозов у детей. Materia Medica. 2000; 1: 72-5.
- Балаболкин И.И., Гребенюк В.Н. Атопический дерматит у детей. М.; Медицина; 1999.
- Ревякина В.А. Атопический дерматит у детей: проблемы диагностики, классификации и клиники. Materia Medica. 2000;1: 41-9.
- Foster C.S., Calonge M. Atopic keratoconjunctivitis. Ophthalmology.1990; 98 (8): 992-1000.
- Power W.J., Tugal-Tutkin I., Foster C.S. Long-term follow-up patients with atopic keratoconjunctivitis. Ophthalmology. 1998; 105 (4): 637-42.